Compare AVDL & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVDL | DGII |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1996 | N/A |
| Metric | AVDL | DGII |
|---|---|---|
| Price | $21.69 | $44.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $19.14 | ★ $48.80 |
| AVG Volume (30 Days) | ★ 1.6M | 314.2K |
| Earning Date | 03-02-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.55 |
| EPS | N/A | ★ 1.12 |
| Revenue | $248,517,000.00 | ★ $448,817,000.00 |
| Revenue This Year | $65.47 | $12.80 |
| Revenue Next Year | $30.88 | $5.47 |
| P/E Ratio | ★ N/A | $39.92 |
| Revenue Growth | ★ 79.88 | 6.40 |
| 52 Week Low | $6.38 | $22.39 |
| 52 Week High | $23.57 | $48.00 |
| Indicator | AVDL | DGII |
|---|---|---|
| Relative Strength Index (RSI) | 63.88 | 54.89 |
| Support Level | $21.52 | $38.90 |
| Resistance Level | $21.69 | $47.73 |
| Average True Range (ATR) | 0.06 | 2.24 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 66.67 | 70.78 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.